Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report
International Journal of Infection 4(1) (2016)
Nawfal R Hussein
Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients
Current Hepatitis Reports 11(4) (2012)
Seyed Moayed Alavian; Kamran Bagheri Lankarani; Ala I. Sharara
Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran
Hepatitis Monthly 13(9) (2013)
Alireza Mehrazmay; Seyed-Moayed Alavian; Maziar Moradi-Lakeh; Mahdi Mokhtari Payam; Amir Hashemi-Meshkini; Bita Behnava; Seyyed Mohammad Miri; Pegah Karimi Elizeh; Seyed Vahid Tabatabaee; Maryam Keshvari; Kamran Bagheri Lankarani
The treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience
Epidemiology and Infection 144(8) (2016)
N. R. HUSSEIN; I. TUNJEL; Z. BASHARAT; A. TAHA; W. IRVING
Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
Hepatitis Monthly 13(11) (2013)
Nasser Ebrahimi Daryani; Seyed Moayed Alavian; Mohammad Hossein Somi; Mohammad Torabi-Nami
Burden of Hepatitis C on Patients with Thalassemia
International Journal of Infection Inpress(Inpress) (2016)
Zahra Sepehri; Seyed Moayed Alavian
Burden of Hepatitis C on Patients with Thalassemia
International Journal of Infection 4(4) (2016)
Zahra Sepehri; Seyed Moayed Alavian
The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
Hepatitis Monthly 16(1) (2016)
Bita Behnava; Heidar Sharafi; Maryam Keshvari; Ali Pouryasin; Leila Mehrnoush; Shima Salimi; Pegah Karimi Elizee; Mehran Ghazimoghaddam; Seyed Moayed Alavian
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India
Journal of Clinical and Experimental Hepatology 4(2) (2014)
Pankaj Puri; Anil C. Anand; Vivek A. Saraswat; Subrat K. Acharya; Shiv K. Sarin; Radha K. Dhiman; Rakesh Aggarwal; Shivaram P. Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K. Dixit; Ajay Duseja; Ajay K. Jain; Dharmesh Kapoor; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P. Misra; Mohan V.G. Prasad; Aabha Nagral; Amarendra S. Puri; R. Jeyamani; Sanjiv Saigal; Samir Shah; Praveen K. Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens
Hepatitis Monthly 18(9) (2018)
Jamshid Vafaeimanesh; Fahimeh Safarnezhad Tameshkel; Hossein Ajdarkosh; Azita Azarkeyvani; Mahmoodreza Khoonsari; Amirhossein Faraji; Masoudreza Sohrabi; Sima Aten; Hossein Keyvani; Farhad Zamani
Hepatitis C Virus Treatment in Non-Liver Organ Transplantation Programs
Current Hepatology Reports 17(2) (2018)
Eduardo A. Rodriguez; Bashar A. Aqel
Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
Hepatitis Monthly 15(1) (2015)
Saleh Sandoughdaran; Seyed Moayed Alavian; Heidar Sharafi; Bita Behnava; Shima Salimi; Leila Mehrnoush; Maryam Keshvari
The Effectiveness of Sofosbuvir and Daclatasvir in the Treatment of Hepatitis C in Thalassaemia Major Patients and their Effect on Haematological Factors
Indian Journal of Medical Microbiology 36(2) (2018)
Farhad Zamani; Hossein Ajdarkosh; Fahimeh Safarnezhad-Tameshkel; Azita Azarkeivan; Hossein Keyvani; Farshad Naserifar; Jamshid Vafaeimanesh
Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study
Archives of Medical Research 53(7) (2022)
Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Bahareh Amirkalali; Nima Motamed; Jamshid Vafaeimanesh; Mansooreh Maadi; Masodreza Sohrabi; Amir Hossein Faraji; Mahmoodreza Khoonsari; Hossein Ajdarkosh; Mehdi Nikkhah; Elham Sobh Rakhashankhah; Farhad Zamani
Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials
Hepatitis Monthly 16(3) (2016)
Ehsan Aminizadeh; Seyed Moayyed Alavian; Ali Akbari Sari; Nasser Ebrahimi Daryani; Bita Behnava
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
Journal of the Formosan Medical Association 117(1) (2018)
Po-Cheng Liang; Pei-Chin Lin; Ching-I. Huang; Chung-Feng Huang; Ming-Lun Yeh; Yu-Sheng Zeng; Wan-Yi Hsu; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Shyh-Shin Chiou; Ming-Lung Yu
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals
Hepatitis Monthly 16(4) (2016)
Khashayar Hesamizadeh; Heidar Sharafi; Mohammad Saeid Rezaee-Zavareh; Bita Behnava; Seyed Moayed Alavian